IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.9600
+0.0372 (4.03%)
Apr 25, 2025, 4:00 PM EDT - Market closed
IO Biotech Employees
IO Biotech had 80 employees as of December 31, 2024. The number of employees increased by 12 or 17.65% compared to the previous year.
Employees
80
Change (1Y)
12
Growth (1Y)
17.65%
Revenue / Employee
n/a
Profits / Employee
-$1,193,638
Market Cap
63.25M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 80 | 12 | 17.65% |
Dec 31, 2023 | 68 | 11 | 19.30% |
Dec 31, 2022 | 57 | 25 | 78.13% |
Dec 31, 2021 | 32 | 21 | 190.91% |
Dec 31, 2020 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IOBT News
- 1 day ago - IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 2 days ago - IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - GlobeNewsWire
- 4 weeks ago - IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 5 weeks ago - IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - GlobeNewsWire
- 7 weeks ago - IO Biotech Reports 2024 Business Highlights - GlobeNewsWire
- 2 months ago - IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference - GlobeNewsWire
- 2 months ago - IO Biotech to Present at the 45th Annual Cowen Health Care Conference - GlobeNewsWire
- 2 months ago - IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate - GlobeNewsWire